Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis.
暂无分享,去创建一个
[1] Kukin Ml. The Heart Outcomes Prevention Evaluation Study. , 2001, Current cardiology reports.
[2] B. Gontero,et al. Angiotensin II induces nuclear factor- kappa B activation in cultured neonatal rat cardiomyocytes through protein kinase C signaling pathway. , 2000, Journal of molecular and cellular cardiology.
[3] S. Yusuf,et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .
[4] H. Haber,et al. Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study) , 2000, Journal of the American College of Cardiology.
[5] P. Libby,et al. Angiotensin induces inflammatory activation of human vascular smooth muscle cells. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[6] U. Ikeda,et al. Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. , 1999, The American journal of cardiology.
[7] M. Runge,et al. Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors. , 1999, Circulation research.
[8] R. Dinsmore,et al. Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. QUIET Investigators. QUinapril Ischemic Event Trial. , 1999, The American journal of cardiology.
[9] H. Drexler,et al. Differential effects of quinaprilat and enalaprilat on endothelial function of conduit arteries in patients with chronic heart failure. , 1998, Circulation.
[10] M. Simoons,et al. The European trial on reduction of cardiac events with perindopril in stable coronary artery disease (EUROPA). , 1998, European heart journal.
[11] M. Pfeffer,et al. Prevention of events with angiotensin-converting enzyme inhibition (the PEACE study design). Prevention of Events with Angiotensin-Converting Enzyme Inhibition. , 1998, The American journal of cardiology.
[12] J. Egido,et al. Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. , 1997, Circulation.
[13] D. Vaughan,et al. Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition. , 1997, Kidney international.
[14] G. Berry,et al. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. , 1996, Circulation.
[15] M. Horiuchi,et al. Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II. , 1996, Circulation research.
[16] F J Schoen,et al. Circumferential stress and matrix metalloproteinase 1 in human coronary atherosclerosis. Implications for plaque rupture. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[17] Michael A. Proschan,et al. Rationale and Design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) , 1996 .
[18] G. B. John Mancini,et al. Angiotensin Converting Enzyme Inhibition, with Quinapril, Improves Endothelial Vasomotor Dysfunction in Patients with Coronary Artery Disease: the TREND Study (Trial on REversing ENdothelial Dysfunction) , 1996 .
[19] M. Olschewski,et al. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. , 1996, Circulation.
[20] T. Lüscher,et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. , 1996, Circulation.
[21] E. Aliot,et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. , 1995, The New England journal of medicine.
[22] D. Vaughan,et al. Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV. , 1995, The Journal of clinical investigation.
[23] A. Schmidt,et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. , 1995, The Journal of clinical investigation.
[24] D. Harrison,et al. Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production. , 1995, Circulation.
[25] T. Lüscher,et al. Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotides and angiotensin1 receptors. , 1995, The Journal of clinical investigation.
[26] P. Libby,et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. , 1995, The Journal of clinical investigation.
[27] T. Maniatis,et al. Transcriptional regulation of endothelial cell adhesion molecules : NF-icB and cytokine-inducible enhancers , 2004 .
[28] P. Libby,et al. Induction and Stabilization of IκBα by Nitric Oxide Mediates Inhibition of NF-κB (*) , 1995, The Journal of Biological Chemistry.
[29] D. Vaughan,et al. Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis. , 1995, The Journal of clinical investigation.
[30] T. Kitazono,et al. Evidence that angiotensin II is present in human monocytes. , 1995, Circulation.
[31] Y. Sasaguri,et al. Effect of angiotensin II and thromboxane A2 on the production of matrix metalloproteinase by human aortic smooth muscle cells. , 1995, Biochemistry and molecular biology international.
[32] R. Alexander. Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. , 1995, Hypertension.
[33] B. Magnani,et al. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction , 1995 .
[34] D. Steinberg,et al. Role of oxidized LDL and antioxidants in atherosclerosis. , 1995, Advances in experimental medicine and biology.
[35] P. Libby,et al. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. , 1995, The Journal of biological chemistry.
[36] H. Rakugi,et al. Potential Importance of Tissue Angiotensin‐Converting Enzyme Inhibition in Preventing Neointima Formation , 1994, Circulation.
[37] A. Maseri,et al. Angiotensin II Increases Plasminogen Activator Inhibitor Type 1 and Tissue‐Type Plasminogen Activator Messenger RNA in Cultured Rat Aortic Smooth Muscle Cells , 1994, Circulation.
[38] T. Resink,et al. Activation of human peripheral monocytes by angiotensin II , 1994, FEBS letters.
[39] R W Alexander,et al. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. , 1994, Circulation research.
[40] G. Gibbons,et al. The emerging concept of vascular remodeling. , 1994, The New England journal of medicine.
[41] R. Re,et al. Tissue angiotensin system in cardiovascular medicine. A paradigm shift? , 1994, Circulation.
[42] J. Krieger,et al. Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis. , 1994, The Journal of clinical investigation.
[43] D. Celermajer,et al. Cigarette Smoking Is Associated With Dose‐Related and Potentially Reversible Impairment of Endothelium‐Dependent Dilation in Healthy Young Adults , 1993, Circulation.
[44] R. Alexander,et al. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. , 1993, The Journal of clinical investigation.
[45] P. Ridker,et al. Stimulation of Plasminogen Activator Inhibitor In Vivo by Infusion of Angiotensin II Evidence of a Potential Interaction Between the Renin‐Angiotensin System and Fibrinolytic Function , 1993, Circulation.
[46] M. J. Fischer,et al. Ramipril prevents impaired endothelium-dependent relaxation in arteries from rabbits fed an atherogenic diet. , 1993, Atherosclerosis.
[47] H. Itoh,et al. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. , 1993, The Journal of clinical investigation.
[48] F. Suzuki,et al. [Renin-angiotensin system]. , 1992, Nihon rinsho. Japanese journal of clinical medicine.
[49] B. Pitt,et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions , 1992, The Lancet.
[50] E. J. Brown,et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.
[51] S. Yusuf,et al. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.
[52] H. Urata,et al. Multiple determinants for the high substrate specificity of an angiotensin II-forming chymase from the human heart. , 1991, The Journal of biological chemistry.
[53] Salim Yusuf,et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.
[54] A. Yeung,et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. , 1990, Circulation.
[55] C. Johnston,et al. Comparative studies of tissue inhibition by angiotensin converting enzyme inhibitors. , 1989, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[56] V. Dzau,et al. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. , 1989, The Journal of clinical investigation.
[57] B. Wintroub,et al. Chemistry of a human monocyte-derived cell line (U937): identification of the angiotensin I-converting activity as leukocyte cathepsin G , 1985 .
[58] W F Ganong,et al. The renin-angiotensin system. , 1978, Annual review of physiology.
[59] C. Wilson,et al. Antitubular basement-membrane antibodies in methicillin-associated interstitial nephritis. , 1974, The New England journal of medicine.
[60] Luscher,et al. Nitric Oxide Inhibits Angiotensin Il-induced Migration of Rat Aortic Smooth Muscle Cell Role of Cyclic-Nucleotides and Angiotensin 1 Receptors , 2022 .